Evaluation of the Role of Laparoscopic Sleeve Gastrectomy and Laparoscopic One Anastomosis Gastric Bypass in the Treatment of Metabolic Syndrome

Abstract Background The dramatic rise in the prevalence of Metabolic Syndrome has become a major global health issue. The problem is complex and will require strategies at many levels to prevent, control and manage. It is well known that obesity has profound effect on tissue sensitivity to insulin and so, leads to glucose intolerance, increased in Blood Pressure and abnormalities in Lipid Profile. Patients and Methods We aimed to compare between laparoscopic mini-gastric bypass and laparoscopic sleeve gastrectomy regarding the efficacy of control of type 2 D.M, Hypertension and Hyperlipidemia in obese patients. It is a prospective study which was done between April 2022 – October 2022 at Ain Shams university hospitals, Cairo, Egypt. This study included 60 obese patients with type 2 D.M with one or both of the following (Hypertension and Hyperlipidemia) and divided into two groups: Group (1): (30 patients) treated by laparoscopic Sleeve gastrectomy, group (2): (30 patients) treated by laparoscopic One anastomosis- Gastric Bypass. Results Complete resolution of diabetes occurred in OAGB cases in 66.7% compared to 55.4% in SG cases at 6 months and cases with no remission in D.M was 0% in OAGB and 16.6% with SG. Regarding the Hypertension, in Group 1 (SG) Resolution Of Hypertension was 55%, Improvement was 25% and No Change in Hypertension Status was 20%, In Group 2 (OAGB) Resolution Of Hypertension was 62.5%, Improvement was 25% and No Change in Hypertension Status was 12.5%, with comparing the 2 groups. Regarding Hyperlipidemia. In Group 1 (SG) Resolution Of Hyperlipidemia was 48%, Improvement was 30% and No Change in Hyperlipidemia Status was 22%, In Group 2 (OAGB) Resolution Of Hyperlipidemia was 60%, Improvement was 24% and No Change in Hypertension Status was 16%. Conclusion Bariatric surgery (SG and OAGB) is not only weight reducing surgery but a metabolic surgery which can cure most of the metabolic syndrome and they are considered the most effective long term treatment modality for type 2 diabetes in obese patients and with comparing between SG and OAGB, our study suggests that Both procedures are highly effective in control of Diabetes, Hypertension.

Authors

Institutions

Publication Details

Journal
QJM
Published
2024-10-01
DOI
https://doi.org/10.1093/qjmed/hcae175.293
Primary Topic
Bariatric Surgery and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of the Role of Laparoscopic Sleeve Gastrectomy and Laparoscopic One Anastomosis Gastric Bypass in the Treatment of Metabolic Syndrome

Ramy Fouad Helmy, M. Aziz, Mahmoud Gamal Mohamed Shatla
QJM
Bariatric Surgery and Outcomes
article

Evaluation of the Role of Laparoscopic Sleeve Gastrectomy and Laparoscopic One Anastomosis Gastric Bypass in the Treatment of Metabolic Syndrome

Ramy Fouad Helmy, M. Aziz, Mahmoud Gamal Mohamed Shatla
article en

Abstract

Abstract Background The dramatic rise in the prevalence of Metabolic Syndrome has become a major global health issue. The problem is complex and will require strategies at many levels to prevent, control and manage. It is well known that obesity has profound effect on tissue sensitivity to insulin and so, leads to glucose intolerance, increased in Blood Pressure and abnormalities in Lipid Profile. Patients and Methods We aimed to compare between laparoscopic mini-gastric bypass and laparoscopic sleeve gastrectomy regarding the efficacy of control of type 2 D.M, Hypertension and Hyperlipidemia in obese patients. It is a prospective study which was done between April 2022 – October 2022 at Ain Shams university hospitals, Cairo, Egypt. This study included 60 obese patients with type 2 D.M with one or both of the following (Hypertension and Hyperlipidemia) and divided into two groups: Group (1): (30 patients) treated by laparoscopic Sleeve gastrectomy, group (2): (30 patients) treated by laparoscopic One anastomosis- Gastric Bypass. Results Complete resolution of diabetes occurred in OAGB cases in 66.7% compared to 55.4% in SG cases at 6 months and cases with no remission in D.M was 0% in OAGB and 16.6% with SG. Regarding the Hypertension, in Group 1 (SG) Resolution Of Hypertension was 55%, Improvement was 25% and No Change in Hypertension Status was 20%, In Group 2 (OAGB) Resolution Of Hypertension was 62.5%, Improvement was 25% and No Change in Hypertension Status was 12.5%, with comparing the 2 groups. Regarding Hyperlipidemia. In Group 1 (SG) Resolution Of Hyperlipidemia was 48%, Improvement was 30% and No Change in Hyperlipidemia Status was 22%, In Group 2 (OAGB) Resolution Of Hyperlipidemia was 60%, Improvement was 24% and No Change in Hypertension Status was 16%. Conclusion Bariatric surgery (SG and OAGB) is not only weight reducing surgery but a metabolic surgery which can cure most of the metabolic syndrome and they are considered the most effective long term treatment modality for type 2 diabetes in obese patients and with comparing between SG and OAGB, our study suggests that Both procedures are highly effective in control of Diabetes, Hypertension.

QJMVol. 117(Supplement_2)
Ain Shams University (EG)
Openalex Percentile: Top 61%
Bariatric Surgery and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.